Viewing StudyNCT00160641



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00160641
Status: COMPLETED
Last Update Posted: 2020-03-27
First Post: 2005-09-08

Brief Title: A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Sponsor: UCB Pharma
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Cimzia View
Rheumatoid Arthritis View
CDP870 View
Certolizumab Pegol View